Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Journal of Ethnopharmacology
|
January 26, 2017
Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice
Yan-Feng Huang, Jiang-Tao Zhou, Chang Qu, et al.
JACS Au
|
June 28, 2024
Multiple Interlayer Interactions Enable Highly Stable X-ray Detection in 2D Hybrid Perovskites
Haiqing Zhong, Shihai You, Jianbo Wu, et al.
Pharmacological Research
|
September 24, 2018
Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota
Xiao-Jun Zhang, Zhong-Wen Yuan, Chang Qu, et al.
The Journal of Machine Learning for Biomedical Imaging
|
April 20, 2023
Compound Figure Separation of Biomedical Images: Mining Large Datasets for Self-supervised Learning
Tianyuan Yao, Chang Qu, Jun Long, et al.
Plos One
|
March 15, 2018
Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice
Xiu-Ting Yu, Yi-Fei Xu, Yan-Feng Huang, et al.
Nature Communications
|
May 24, 2022
Anoctamin 1 controls bone resorption by coupling Cl<sup>-</sup> channel activation with RANKL-RANK signaling transduction
Weijia Sun, Shuai Guo, Yuheng Li, et al.
Antiviral Research
|
November 27, 2010
Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection
Ying Pei, Yang-Fei Xiang, Jia-Nan Chen, et al.
Signal Transduction and Targeted Therapy
|
June 6, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Jing Zhang, et al.
Nature Communications
|
June 27, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.
Signal Transduction and Targeted Therapy
|
January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Journal of Ethnopharmacology
|
January 26, 2017
Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice
Yan-Feng Huang, Jiang-Tao Zhou, Chang Qu, et al.
JACS Au
|
June 28, 2024
Multiple Interlayer Interactions Enable Highly Stable X-ray Detection in 2D Hybrid Perovskites
Haiqing Zhong, Shihai You, Jianbo Wu, et al.
Pharmacological Research
|
September 24, 2018
Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota
Xiao-Jun Zhang, Zhong-Wen Yuan, Chang Qu, et al.
The Journal of Machine Learning for Biomedical Imaging
|
April 20, 2023
Compound Figure Separation of Biomedical Images: Mining Large Datasets for Self-supervised Learning
Tianyuan Yao, Chang Qu, Jun Long, et al.
Plos One
|
March 15, 2018
Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice
Xiu-Ting Yu, Yi-Fei Xu, Yan-Feng Huang, et al.
Nature Communications
|
May 24, 2022
Anoctamin 1 controls bone resorption by coupling Cl<sup>-</sup> channel activation with RANKL-RANK signaling transduction
Weijia Sun, Shuai Guo, Yuheng Li, et al.
Antiviral Research
|
November 27, 2010
Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection
Ying Pei, Yang-Fei Xiang, Jia-Nan Chen, et al.
Signal Transduction and Targeted Therapy
|
June 6, 2022
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Jing Zhang, et al.
Nature Communications
|
June 27, 2022
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Li Fang Du, et al.
Signal Transduction and Targeted Therapy
|
January 3, 2023
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
Nawal Al Kaabi, Yun Kai Yang, Yu Liang, et al.
Page
of 9